BiotechTube
Home/Pipeline/LBS-008

LBS-008

Stargardt Disease

Phase 3Active

Key Facts

Indication
Stargardt Disease
Phase
Phase 3
Status
Active
Company
Lin BioScience

About Lin BioScience

Taiwan‑based biotech developing oral small‑molecule drugs for eye disease, cancer and metabolic disorders, with multiple FDA‑designated clinical programs.

View full company profile

Therapeutic Areas

OphthalmologyOncologyMetabolic Disease

Other Stargardt Disease Drugs

DrugCompanyPhase
KIO-301Kiora PharmaceuticalsPreclinical
EIR-0205EIR BiopharmaPreclinical
Emixustat HClKubota VisionPhase 3
Gildeuretinol (ALK-001)Alkeus PharmaceuticalsPhase 3
MCO-010Nanoscope TherapeuticsPhase 2
SB-007SpliceBioPhase 1/2
OCU410STOcugenPhase 2/3
ABO-504Abeona TherapeuticsPreclinical